However, when calorie intake drops too low for too long, the body can respond in ways that work against your goals
Retatrutide has Phase 3 safety data, but MOTS-c data is mostly from animals and one related analog trial
Why Are There Concerns About Bipolar Disorder and Medications
Semaglutide leads the risk profile With a reporting odds ratio of 2.46 in the FAERS database, semaglutide carries the highest documented risk of alopecia among GLP-1 receptor agonists
Key study characteristics were extracted, including first author, publication year, country, study design, GLP-1RA type, comparator group, outcome(s) of interest, follow-up duration, sample size, mean age, standard deviation (if available), and percentage of male participants